FINCH THERAPEUTICS GROUP INC - COM (FNCH)

CUSIP: 31773D101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
9,588,250
Share change
-452,051
Total reported value
$4,602,141
Price per share
$0.48
Number of holders
36
Value change
-$524,990
Number of buys
10
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 31773D101?
CUSIP 31773D101 identifies FNCH - FINCH THERAPEUTICS GROUP INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FINCH THERAPEUTICS GROUP INC - COM (FNCH) as of Q4 2022

As of 31 Dec 2022, FINCH THERAPEUTICS GROUP INC - COM (FNCH) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,588,250 shares. The largest 10 holders included SUSQUEHANNA INTERNATIONAL GROUP, LLP, Avenir Management Company, LLC, BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, Bleichroeder LP, LAKE STREET ADVISORS GROUP, LLC, TRB Advisors LP, SVB WEALTH LLC, Ikarian Capital, LLC, and Oasis Management Co Ltd.. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.